Exelixis Inc

Links: Y! EXEL chart/quote @ Y! F

EXEL / Message Board

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
24730	Re: Cabozantinib/Atezolizumab Combo Shows Promise in Previously-Treated Urothelial Carcinoma	GN	JoeFlow		1	5/30/2020 8:42:41 PM

24729	Cabozantinib/Atezolizumab Combo Shows Promise in Previously-Treated Urothelial Carcinoma	GN	Pacific		2	5/30/2020 6:03:28 PM

24728	ASCO 2020: Cabozantinib in Combination with Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: Results of Cohort 6 of the COSMIC-021 Study	GN	Pacific		6	5/30/2020 12:57:58 PM

24727	Re: Is There An Opportunity With Exelixis, Inc.'s (NASDAQ:EXEL) 49% Undervaluation?	GN	TaiTienMuyBien		2	5/30/2020 8:22:56 AM

24726	Re: Is There An Opportunity With Exelixis, Inc.'s (NASDAQ:EXEL) 49% Undervaluation?	GN	indyengineer		3	5/30/2020 4:55:09 AM

24725	Re: Is There An Opportunity With Exelixis, Inc.'s (NASDAQ:EXEL) 49% Undervaluation?	GN	TaiTienMuyBien		4	5/29/2020 7:29:28 PM

24724	Re: Is There An Opportunity With Exelixis, Inc.'s (NASDAQ:EXEL) 49% Undervaluation?	GN	indyengineer		4	5/29/2020 5:14:56 PM

24723	Exelixis (EXEL) Investor Presentation	GN	ELefevre		0	5/29/2020 1:40:12 PM

24722	Re: Is There An Opportunity With Exelixis, Inc.'s (NASDAQ:EXEL) 49% Undervaluation?	GN	JoeFlow		3	5/28/2020 9:47:34 PM

24721	Re: Is There An Opportunity With Exelixis, Inc.'s (NASDAQ:EXEL) 49% Undervaluation?	GN	TaiTienMuyBien		0	5/28/2020 9:26:33 PM


	About Us • Contact Us • Follow Us on Twitter • Members Directory • Help Center • Advertise Not a member yet? What are you waiting for? Create Account Want to contribute? Support InvestorVillage by donating © 2003-2019 Investorvillage.com. All rights reserved. User Agreement